Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Chem Biol ; 15(8): 2164-2174, 2020 08 21.
Article in English | MEDLINE | ID: mdl-32589399

ABSTRACT

Thiopeptide antibiotics are emerging clinical candidates that exhibit potent antibacterial activity against a variety of intracellular pathogens, including Mycobacterium tuberculosis (Mtb). Many thiopeptides directly inhibit bacterial growth by disrupting protein synthesis. However, recent work has shown that one thiopeptide, thiostrepton (TSR), can also induce autophagy in infected macrophages, which has the potential to be exploited for host-directed therapies against intracellular pathogens, such as Mtb. To better define the therapeutic potential of this class of antibiotics, we studied the host-directed effects of a suite of natural thiopeptides that spans five structurally diverse thiopeptide classes, as well as several analogs. We discovered that thiopeptides as a class induce selective autophagic removal of mitochondria, known as mitophagy. This activity is independent of other biological activities, such as proteasome inhibition or antibiotic activity. We also find that many thiopeptides exhibit potent activity against intracellular Mtb in macrophage infection models. However, the thiopeptide-induced mitophagy occurs outside of pathogen-containing autophagosomes and does not appear to contribute to thiopeptide control of intracellular Mtb. These results expand basic understanding of thiopeptide biology and provide key guidance for the development of new thiopeptide antibiotics and host-directed therapeutics.


Subject(s)
Mitophagy/drug effects , Peptides/pharmacology , Proteasome Endopeptidase Complex/metabolism , Sulfhydryl Compounds/chemistry , Animals , Anti-Bacterial Agents/pharmacology , Eukaryotic Initiation Factor-2/metabolism , Forkhead Box Protein M1/metabolism , Mice , Mycobacterium tuberculosis/drug effects , Peptides/chemistry , Phosphorylation , RAW 264.7 Cells
2.
Biochem Mol Biol Educ ; 45(5): 403-410, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28294503

ABSTRACT

Here, we present a 10-week project-oriented laboratory module designed to provide a course-based undergraduate research experience in biochemistry that emphasizes the importance of biomolecular structure and dynamics in enzyme function. This module explores the impact of mutagenesis on an important active site loop for a biomedically-relevant human enzyme, protein tyrosine phosphatase 1B (PTP1B). Over the course of the semester students guide their own mutant of PTP1B from conception to characterization in a cost-effective manner and gain exposure to fundamental techniques in biochemistry, including site-directed DNA mutagenesis, bacterial recombinant protein expression, affinity column purification, protein quantitation, SDS-PAGE, and enzyme kinetics. This project-based approach allows an instructor to simulate a research setting and prepare students for productive research beyond the classroom. Potential modifications to expand or contract this module are also provided. © 2017 by The International Union of Biochemistry and Molecular Biology, 45(5):403-410, 2017.


Subject(s)
Biochemistry/education , Laboratories , Protein Tyrosine Phosphatase, Non-Receptor Type 1/chemistry , Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism , Research/education , Humans , Protein Conformation , Protein Tyrosine Phosphatase, Non-Receptor Type 1/isolation & purification , Students
3.
Biochemistry ; 56(1): 96-106, 2017 Jan 10.
Article in English | MEDLINE | ID: mdl-27959494

ABSTRACT

Protein tyrosine phosphatase 1B (PTP1B) is a known regulator of the insulin and leptin signaling pathways and is an active target for the design of inhibitors for the treatment of type II diabetes and obesity. Recently, cichoric acid (CHA) and chlorogenic acid (CGA) were predicted by docking methods to be allosteric inhibitors that bind distal to the active site. However, using a combination of steady-state inhibition kinetics, solution nuclear magnetic resonance experiments, and molecular dynamics simulations, we show that CHA is a competitive inhibitor that binds in the active site of PTP1B. CGA, while a noncompetitive inhibitor, binds in the second aryl phosphate binding site, rather than the predicted benzfuran binding pocket. The molecular dynamics simulations of the apo enzyme and cysteine-phosphoryl intermediate states with and without bound CGA suggest CGA binding inhibits PTP1B by altering hydrogen bonding patterns at the active site. This study provides a mechanistic understanding of the allosteric inhibition of PTP1B.


Subject(s)
Caffeic Acids/pharmacology , Chlorogenic Acid/pharmacology , Enzyme Inhibitors/pharmacology , Protein Tyrosine Phosphatase, Non-Receptor Type 1/antagonists & inhibitors , Succinates/pharmacology , Algorithms , Allosteric Regulation , Binding Sites , Binding, Competitive , Caffeic Acids/chemistry , Caffeic Acids/metabolism , Catalytic Domain , Chlorogenic Acid/chemistry , Chlorogenic Acid/metabolism , Enzyme Inhibitors/metabolism , Humans , Hydrogen Bonding , Kinetics , Magnetic Resonance Spectroscopy , Molecular Dynamics Simulation , Protein Binding , Protein Domains , Protein Tyrosine Phosphatase, Non-Receptor Type 1/chemistry , Protein Tyrosine Phosphatase, Non-Receptor Type 1/metabolism , Succinates/chemistry , Succinates/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...